1st Quarter - Report

BGR GOVERNMENT AFFAIRS for ADAMS RESPIRATORY THERAPEUTICS

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Monitoring and guidance with regard to FDA enforcement action, DXM-related litigation

LobbyistCovered position, as disclosed
JENNIFER LARKIN LUKAWSKI —
EDWARD ROGERS —
SHALLA ROSS —
ROBERT WOOD —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.